ORG Wealth Partners LLC Invests $42,000 in Astera Labs, Inc. (NASDAQ:ALAB)

ORG Wealth Partners LLC bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALABFree Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 319 shares of the company’s stock, valued at approximately $42,000.

A number of other hedge funds and other institutional investors have also modified their holdings of ALAB. Hollencrest Capital Management purchased a new stake in shares of Astera Labs during the third quarter worth about $26,000. US Bancorp DE purchased a new stake in shares of Astera Labs during the third quarter worth about $46,000. First Horizon Advisors Inc. purchased a new stake in shares of Astera Labs during the third quarter worth about $49,000. Allworth Financial LP increased its holdings in Astera Labs by 445.5% in the third quarter. Allworth Financial LP now owns 1,091 shares of the company’s stock valued at $57,000 after buying an additional 891 shares during the last quarter. Finally, GAMMA Investing LLC increased its holdings in Astera Labs by 78.3% in the fourth quarter. GAMMA Investing LLC now owns 510 shares of the company’s stock valued at $68,000 after buying an additional 224 shares during the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages recently weighed in on ALAB. Northland Securities lowered Astera Labs from an “outperform” rating to a “market perform” rating and boosted their price objective for the company from $100.00 to $120.00 in a report on Thursday, January 2nd. Northland Capmk lowered Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Thursday, January 2nd. Stifel Nicolaus boosted their price objective on Astera Labs from $100.00 to $150.00 and gave the company a “buy” rating in a report on Monday, January 6th. Craig Hallum boosted their price objective on Astera Labs from $75.00 to $105.00 and gave the company a “buy” rating in a report on Tuesday, November 5th. Finally, JPMorgan Chase & Co. boosted their price objective on Astera Labs from $70.00 to $110.00 and gave the company an “overweight” rating in a report on Tuesday, November 5th. Two analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus target price of $105.75.

Check Out Our Latest Research Report on ALAB

Astera Labs Trading Down 0.8 %

Shares of NASDAQ ALAB opened at $129.70 on Friday. The stock has a 50 day simple moving average of $115.73 and a 200-day simple moving average of $74.04. Astera Labs, Inc. has a 12-month low of $36.22 and a 12-month high of $147.39.

Astera Labs (NASDAQ:ALABGet Free Report) last issued its quarterly earnings data on Monday, November 4th. The company reported $0.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.06. The business had revenue of $113.10 million during the quarter, compared to the consensus estimate of $97.50 million. Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%. Astera Labs’s quarterly revenue was up 47.1% on a year-over-year basis. As a group, equities analysts forecast that Astera Labs, Inc. will post -0.45 earnings per share for the current year.

Insider Transactions at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 12,000 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $94.74, for a total value of $1,136,880.00. Following the completion of the sale, the director now directly owns 483,863 shares in the company, valued at $45,841,180.62. This represents a 2.42 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Jitendra Mohan sold 171,064 shares of the company’s stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $103.53, for a total value of $17,710,255.92. Following the completion of the sale, the chief executive officer now owns 628,895 shares of the company’s stock, valued at $65,109,499.35. This trade represents a 21.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,690,452 shares of company stock worth $167,581,256.

Astera Labs Company Profile

(Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Read More

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.